Stability and bioequivalence studies of two marketed formulations of coenzyme Q10 in beagle dogs

Chemical and Pharmaceutical Bulletin

Volumn 47, Issue 7, 1999, Pages 1024-1028

  Kommuru, Thirumala R ^a   Ashraf, Mohammad ^b   Khan, Mansoor A ^c   Reddy, Indra K ^a,c  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b PFIZER INC   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Antioxidants; Bioavailability; Coezyme Q10; Stability

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; ASCORBIC ACID; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; EDETIC ACID; GALLIC ACID PROPYL ESTER; UBIDECARENONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CAPSULE FILLING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG FORMULATION; DRUG MARKETING; DRUG STABILITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; THERMOSTABILITY;

EID: 0032770065     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.47.1024     Document Type: Article

References (20)

1. Folkers K., Wolaniuk A., Vadhanavikit S., Sakmato N., Takemura K., Baker L., Richardson P. C., "Biomedical and clinical aspects of Coenzyme Q," Vol. 5, ed. by Folkers K., Yamamura Y., Elsevier, Amsterdam, 1986, pp. 375-391.
2. Greenberg S., Fishman W. H., J. Clin. Pharmacol., 30, 590-608 (1990).
3. Kishi H., Kanamori N., Nishii S., Hiraoka E., Okamato T., Kishi T., "Biomedical and clinical aspects of Coenzyme Q," ed. by Folkers K., Yamamura Y., Chapter 3, Elsevier Science, Amsterdam, 1984, pp. 131-142.
4. Weis M., Mortensen S. A., Rassing M. R., Moller-Sonnergaard J., Poulsen G., Rasmussen S. N., Mol. Aspects Med., 15, S273-S278 (1994).
5. Chopra R. K., Goldman R., Sinatra S. T., Bhagavan H., Int. J. Vit. Nutr. Res. 68, 109-113 (1998).
6. Matsuda Y., Masahara R., J. Pharm. Sci., 72, 1198-1203 (1983).
7. Chalmers L., Antioxidants: Research and development report. S.P.C. (1971) 29-38.
8. Kommuru T. R., Khan M. A., Ashraf M., Kattenacker R., Reddy I. K., J. Pharm. Biomed. Anal., 16, 1037-1040, (1998).
9. Kaikkonen J., Nyssonen K., Porkkala-Sarataho E., Poulsen H. E., Metsa-Ketela T., Hayn M., Salonen R., Salonen J. T., Free Rad. Biol. Med., 22, 1195-1202 (1997).
10. Bogentoft C., Edlund P. O., Olsson B., Wilund L., Westensen K., "Biomedical and clinical aspects of Coenzyme Q," Chapter 6, ed. by Folkers K., Yamamura Y., Elsevier, Amsterdam, 1991, pp. 215-224.
11. Tomono Y., Hasegawa J., Seki T., Motegi K., Morishita N., Int. J. Clin. Pharmacology, Therapy and Toxicology, 24, 536-541 (1986).
12. Sanma H., Yamada H., Yamano Y., Tanaka M., Tajima T., Kanazawa T., Hori S., Nakazawa H., Yoshino H., Miyamori R., Kojima M., Nakamura Y., "Biomedical and Clinical Aspects of Coenzyme Q," Vol. 5, ed. by Folkers K., Yamamura Y., Elsevier, Amsterdam, 1986, pp. 99-100.
13. Langsjoen P. H., Langsjoen P., Folkers K., Am. J. Cardiol., 65, 521-523 (1989).
14. Stella V. J., Charman W. N. A., Int. J. Pharm., 34, 175-178 (1986).
15. Aso Y. Mishima K., Arisaka T., Kitagawa H., Abstracts of Papers, 1st Symposium on Drug Metabolism and Action, Chiba, November 1969, p. 4-(1).
16. Palin K. J., Wilson C. J., Davis S. S., Philips A. J., J. Pharmcol., 34, 707-710 (1982).
17. Katayama K., Fujita T., Chem. Pharm. Bull., 20, 2585-2592 (1972).
18. Handbook of Pharmaceutical excipients, American Pharmaceutical Association. Washington D.C., 1986, p. 176.
19. Johson D. M., Gu L. C., "Encyclopedia of Pharmaceutical Technology," Vol. 1, ed. by Swarbrick J., Boylan J. C., Marcel Dekker, NY 1988, pp. 415-450.
20. Anderson N. H., Johnston D., Mclelland M. A., Munden P., J. Pharm. & Biomed. Anal., 9, 443-449 (1991).